Mounjaro is India’s highest-selling drug – overtaking antibiotics – eight months after it was approved for sale in the country. lmaas Masood/ReutersMounjaro is India’s highest-selling drug – overtaking antibiotics – eight months after it was approved for sale in the country. lmaas Masood/ReutersIndia’s doctors sound alarm over boom in availability of weight loss jabsCountry is facing epidemic of diabetes and obesity, but experts say widespread and unregulated use of weight loss drugs could put patients at riskIndia’s leading doctors have warned of the dangers of an unregulated boom in weight loss injections, and emphasised they are not a magic pill to solve the country’s growing epidemic of diabetes and obesity. Demand for appetite-suppressing drugs such as Mounjaro, Wegovy and Ozempic has surged since they were introduced into the Indian market this year. In the eight months since it was approved for sale, Mounjaro – a jab that regulates blood sugar and suppresses appetite to help with diabetes and obesity – is now India’s highest-selling drug, overtaking antibiotics. Its commercial success has led its producer, the drug company Eli Lilly, to begin trials on a similar drug that works on suppressing appetite, and could be released in India in pill form by next year. How weight-loss wonder drugs are redefining the way our bodies workRead moreAn Eli Lilly spokesperson said: “Rising urbanisation, sedentary lifestyles, and changing diets have made weight management a growing public health priority.
